Murphy, Á C <br/><br/>
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach.  [electronic resource] 

 -  Cell death & disease  May 2013 
 - e629 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2013.157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Algorithms<br/>Antineoplastic Agents, Alkylating--toxicity<br/>Apoptosis Regulatory Proteins<br/>Apoptotic Protease-Activating Factor 1--metabolism<br/>Brain Neoplasms--metabolism<br/>Caspase 3--metabolism<br/>Caspase 9--metabolism<br/>Caspases--metabolism<br/>Cell Survival--drug effects<br/>Dacarbazine--analogs & derivatives<br/>Disease-Free Survival<br/>Female<br/>Glioblastoma--metabolism<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Male<br/>Middle Aged<br/>Mitochondrial Proteins--metabolism<br/>Temozolomide<br/>X-Linked Inhibitor of Apoptosis Protein--metabolism